Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma

Clinical trial NCT00014443 · TERMINATED

Trial details

NCT number: NCT00014443
Sponsor: Rush University Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2000-08-01
Primary completion: 2003-08-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.